You just read:

Seattle Children's Reprogrammed T Cell Immunotherapy Clinical Trial Boasts 85% Complete Remission Rate in Children with Relapsed Leukemia

News provided by

Seattle Children’s

Dec 09, 2014, 09:00 ET